Regarding the therapeutic effects of CD34+ cells in cerebral ischemia, Taguchi et al. have clarified that CB-derived CD34+ cells ameliorated angiogenesis and neurogenesis rates (Taguchi et al., 2004). This evidence concerns the gene CD34 and brain ischemia.